These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35240960)

  • 1. Computational Modeling on Binding Interactions of Cyclodextrin s with the Human Multidrug Resistance P-glycoprotein Toward Efficient Drug-delivery System Applications.
    González-Durruthy M; Concu R; Osmari Vendrame LF; Ortiz Martins M; Zanella I; Ruso JM; Dias Soeiro Cordeiro MN
    Curr Top Med Chem; 2023; 23(1):62-75. PubMed ID: 35240960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling drug-drug interactions of AZD1208 with Vincristine and Daunorubicin on ligand-extrusion binding TMD-domains of multidrug resistance P-glycoprotein (ABCB1).
    Marques MB; de Oliveira PV; Fagan SB; Oliveira BR; da Silva Nornberg BF; Almeida DV; Marins LF; González-Durruthy M
    Toxicology; 2019 Jan; 411():81-92. PubMed ID: 30339824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homology Modeling of the Human P-glycoprotein (ABCB1) and Insights into Ligand Binding through Molecular Docking Studies.
    Mora Lagares L; Minovski N; Caballero Alfonso AY; Benfenati E; Wellens S; Culot M; Gosselet F; Novič M
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding Site Interactions of Modulators of Breast Cancer Resistance Protein, Multidrug Resistance-Associated Protein 2, and P-Glycoprotein Activity.
    Deng F; Ghemtio L; Grazhdankin E; Wipf P; Xhaard H; Kidron H
    Mol Pharm; 2020 Jul; 17(7):2398-2410. PubMed ID: 32496785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a detergent micelle environment on P-glycoprotein (ABCB1)-ligand interactions.
    Shukla S; Abel B; Chufan EE; Ambudkar SV
    J Biol Chem; 2017 Apr; 292(17):7066-7076. PubMed ID: 28283574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-protein hydrogen bonds govern the inhibition of the ATP hydrolysis of the multidrug transporter P-glycoprotein.
    Chufan EE; Kapoor K; Ambudkar SV
    Biochem Pharmacol; 2016 Feb; 101():40-53. PubMed ID: 26686578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for the Interaction of A
    Abel B; Tosh DK; Durell SR; Murakami M; Vahedi S; Jacobson KA; Ambudkar SV
    Mol Pharmacol; 2019 Aug; 96(2):180-192. PubMed ID: 31127007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand and structure-based classification models for prediction of P-glycoprotein inhibitors.
    Klepsch F; Vasanthanathan P; Ecker GF
    J Chem Inf Model; 2014 Jan; 54(1):218-29. PubMed ID: 24050383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential drug candidates as P-glycoprotein inhibitors to reverse multidrug resistance in cancer: an
    Ibrahim MAA; Abdeljawaad KAA; Jaragh-Alhadad LA; Oraby HF; Atia MAM; Alzahrani OR; Mekhemer GAH; Moustafa MF; Shawky AM; Sidhom PA; Abdelrahman AHM
    J Biomol Struct Dyn; 2023; 41(23):13977-13992. PubMed ID: 36883864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico study of desmosdumotin as an anticancer agent: homology modeling, docking and molecular dynamics simulation approach.
    Gadhe CG; Kothandan G; Cho SJ
    Anticancer Agents Med Chem; 2013 Dec; 13(10):1636-44. PubMed ID: 23796247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efflux mechanism and pathway of verapamil pumping by human P-glycoprotein.
    Wang L; Sun Y
    Arch Biochem Biophys; 2020 Dec; 696():108675. PubMed ID: 33197430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insight into the molecular mechanism of P-glycoprotein mediated drug toxicity induced by bioflavonoids: an integrated computational approach.
    Wongrattanakamon P; Lee VS; Nimmanpipug P; Sirithunyalug B; Chansakaow S; Jiranusornkul S
    Toxicol Mech Methods; 2017 May; 27(4):253-271. PubMed ID: 27996361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and Characterization of Bodipy-FL-Cyclosporine A as a Substrate for Multidrug Resistance-Linked P-Glycoprotein (ABCB1).
    Sajid A; Raju N; Lusvarghi S; Vahedi S; Swenson RE; Ambudkar SV
    Drug Metab Dispos; 2019 Oct; 47(10):1013-1023. PubMed ID: 31371421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Silico Prediction of P-glycoprotein Binding: Insights from Molecular Docking Studies.
    Vilar S; Sobarzo-Sánchez E; Uriarte E
    Curr Med Chem; 2019; 26(10):1746-1760. PubMed ID: 29189117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced delivery of quercetin and doxorubicin using β-cyclodextrin polymer to overcome P-glycoprotein mediated multidrug resistance.
    Pawar CS; Rajendra Prasad N; Yadav P; Muthu Vijayan Enoch IV; Manikantan V; Dey B; Baruah P
    Int J Pharm; 2023 Mar; 635():122763. PubMed ID: 36822336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global alteration of the drug-binding pocket of human P-glycoprotein (ABCB1) by substitution of fifteen conserved residues reveals a negative correlation between substrate size and transport efficiency.
    Vahedi S; Chufan EE; Ambudkar SV
    Biochem Pharmacol; 2017 Nov; 143():53-64. PubMed ID: 28728917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes.
    To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G
    J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-Function Relationships in the Human P-Glycoprotein (ABCB1): Insights from Molecular Dynamics Simulations.
    Mora Lagares L; Pérez-Castillo Y; Minovski N; Novič M
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isopetasin and S-isopetasin as novel P-glycoprotein inhibitors against multidrug-resistant cancer cells.
    Abdelfatah S; Böckers M; Asensio M; Kadioglu O; Klinger A; Fleischer E; Efferth T
    Phytomedicine; 2021 Jun; 86():153196. PubMed ID: 32229058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marine sponge-derived sipholane triterpenoids reverse P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells.
    Abraham I; Jain S; Wu CP; Khanfar MA; Kuang Y; Dai CL; Shi Z; Chen X; Fu L; Ambudkar SV; El Sayed K; Chen ZS
    Biochem Pharmacol; 2010 Nov; 80(10):1497-506. PubMed ID: 20696137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.